A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures
Clinical trial NCT04519645 · TERMINATED
Trial details
- NCT number
- NCT04519645
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2024-08-06
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.